Jane Street’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.58M | Buy |
930,900
+244,100
| +36% | +$2.21M | ﹤0.01% | 2902 |
|
|
2025
Q4 | $4.62M | Buy |
686,800
+72,500
| +12% | +$547K | ﹤0.01% | 3357 |
|
|
2025
Q3 | $5.33M | Buy |
614,300
+149,600
| +32% | +$1.16M | ﹤0.01% | 3332 |
|
|
2025
Q2 | $2.93M | Sell |
464,700
-89,300
| -16% | -$591K | ﹤0.01% | 3793 |
|
|
2025
Q1 | $3.55M | Sell |
554,000
-131,600
| -19% | -$1.09M | ﹤0.01% | 3452 |
|
|
2024
Q4 | $5.51M | Sell |
685,600
-382,200
| -36% | -$3.68M | ﹤0.01% | 2534 |
|
|
2024
Q3 | $13.5M | Buy |
1,067,800
+214,100
| +25% | +$2.76M | ﹤0.01% | 1618 |
|
|
2024
Q2 | $10.8M | Sell |
853,700
-68,100
| -7% | -$685K | ﹤0.01% | 1962 |
|
|
2024
Q1 | $4.41M | Buy |
921,800
+573,900
| +165% | +$2.66M | ﹤0.01% | 2813 |
|
|
2023
Q4 | $1.67M | Sell |
347,900
-237,500
| -41% | -$1.45M | ﹤0.01% | 4654 |
|
|
2023
Q3 | $4.24M | Buy |
585,400
+212,100
| +57% | +$1.69M | ﹤0.01% | 2850 |
|
|
2023
Q2 | $2.77M | Buy |
373,300
+73,600
| +25% | +$579K | ﹤0.01% | 3635 |
|
|
2023
Q1 | $2.08M | Sell |
299,700
-297,000
| -50% | -$2.73M | ﹤0.01% | 3748 |
|
|
2022
Q4 | $6.13M | Sell |
596,700
-6,400
| -1% | -$113K | ﹤0.01% | 2219 |
|
|
2022
Q3 | $11M | Sell |
603,100
-219,000
| -27% | -$9.49M | ﹤0.01% | 1594 |
|
|
2022
Q2 | $42.3M | Sell |
822,100
-7,900
| -1% | -$409K | 0.02% | 630 |
|
|
2022
Q1 | $61.1M | Sell |
830,000
-330,000
| -28% | -$29.4M | 0.02% | 589 |
|
|
2021
Q4 | $166M | Sell |
1,160,000
-132,000
| -10% | -$22.7M | 0.05% | 227 |
|
|
2021
Q3 | $268M | Buy |
1,292,000
+527,900
| +69% | +$116M | 0.09% | 121 |
|
|
2021
Q2 | $162M | Buy |
764,100
+134,200
| +21% | +$24.6M | 0.06% | 211 |
|
|
2021
Q1 | $114M | Buy |
629,900
+115,500
| +22% | +$23M | 0.06% | 232 |
|
|
2020
Q4 | $57.4M | Sell |
514,400
-411,000
| -44% | -$43.7M | 0.03% | 410 |
|
|
2020
Q3 | $100M | Buy |
925,400
+339,900
| +58% | +$41.4M | 0.06% | 215 |
|
|
2020
Q2 | $48.8M | Buy |
585,500
+461,700
| +373% | +$17.7M | 0.04% | 372 |
|
|
2020
Q1 | $1.68M | Buy |
+123,800
| New | +$1.05M | ﹤0.01% | 2191 |
|
|
2018
Q1 | – | Sell |
-605
| Closed | -$15K | – | 5212 |
|
|
2017
Q4 | $15K | Buy |
+605
| New | +$14.8K | ﹤0.01% | 4479 |
|
|
2017
Q1 | – | Sell |
-825
| Closed | -$21K | – | 4516 |
|
|
2016
Q4 | $21K | Sell |
825
-16,960
| -95% | -$495K | ﹤0.01% | 3958 |
|
|
2016
Q3 | $740K | Buy |
17,785
+16,830
| +1,762% | +$2.17M | ﹤0.01% | 2319 |
|
|
2016
Q2 | $139K | Buy |
+955
| New | +$109K | ﹤0.01% | 3840 |
|
|
2016
Q1 | – | Sell |
-1,100
| Closed | -$185K | – | 4483 |
|
|
2015
Q4 | $185K | Buy |
+1,100
| New | +$169K | ﹤0.01% | 3642 |
|
|
2015
Q3 | – | Sell |
-505
| Closed | -$113K | – | 3980 |
|
|
2015
Q2 | $113K | Sell |
505
-1,070
| -68% | -$188K | ﹤0.01% | 3410 |
|
|
2015
Q1 | $261K | Buy |
1,575
+775
| +97% | +$126K | ﹤0.01% | 2640 |
|
|
2014
Q4 | $95K | Buy |
+800
| New | +$83.6K | ﹤0.01% | 2339 |
|
Other funds holding NVAX
SCM
VPM
VCM
S
Jane Street's NVAX Position: Q1 2026 in Review
Jane Street reduced its Novavax (NVAX) stake by 88% in Q1 2026, selling an estimated $4.11M and leaving 64,157 shares worth $522K. The position accounts for ﹤0.01% of the portfolio, ranked #7955.
Jane Street first reported a position in NVAX in Q3 2013 and has held it in 40 quarters since. The position peaked at $93M in Q4 2021. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.
- Jane Street held 64,157 shares of Novavax worth $522K as of Q1 2026.
- Jane Street sold 453,486 Novavax shares in Q1 2026, an estimated $4.11M.
- Novavax made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #7955 holding.
- Jane Street first reported a position in Novavax in Q3 2013 and has held it in 40 quarters since.
- Jane Street's Novavax position peaked at $93M in Q4 2021.
- 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.